Use of short-acting beta-2 agonists (SABA) and exacerbations in a nationwide Swedish asthma cohort (HERA)

C. Janson (Uppsala, Sweden), B. Nwaru (Lund, Sweden), L. Hasvold (Sodertalje, Sweden), F. Wicklund (Uppsala, Sweden), G. Telg (Sodetalje, Sweden), M. Ekstrom (Gothenburg, Sweden)

Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Session: Asthma treatment: cohorts and real-world studies
Session type: Thematic Poster
Number: 2554
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Janson (Uppsala, Sweden), B. Nwaru (Lund, Sweden), L. Hasvold (Sodertalje, Sweden), F. Wicklund (Uppsala, Sweden), G. Telg (Sodetalje, Sweden), M. Ekstrom (Gothenburg, Sweden). Use of short-acting beta-2 agonists (SABA) and exacerbations in a nationwide Swedish asthma cohort (HERA). 2554

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: